PriMatrix for the Management of Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

PriMatrix Dermal Repair Scaffold

Application of PriMatrix to ulcer

DEVICE

Secondary Dressings

Dressings to ensure moist wound environment

DEVICE

Offloading device

Offloading device to decrease pressure to wound area

Trial Locations (17)

10029

The Mount Sinai Medical Center, New York

17402

Martin Foot and Ankle, York

20057

Georgetown University, Washington D.C.

33169

Barry University Clinical Research, North Miami

33406

LA Podiatry Group, West Palm Beach

62226

Podiatry 1st, Belleville

74146

Wound Care of Tulsa, Tulsa

75208

Podiatric Medical Partners of Texas, P.A., Dallas

75390

UT Southwestern Medical Center, Dallas

76104

JPS Health Network, Fort Worth

78229

Element Research Group, San Antonio

78501

Futuro Clinical Trials, McAllen

84770

Foot and Ankle Institute, St. George

90057

LA Foot & Ankle Clinic, Los Angeles

92009

ILD Research Center, Carlsbad

93662

Central Valley Vein and Wound, Selma

94115

Center for Clinical Research, Inc., San Francisco

All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY

NCT03010319 - PriMatrix for the Management of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter